Last reviewed · How we verify
Autologous Cold Stored Platelet transfusion
At a glance
| Generic name | Autologous Cold Stored Platelet transfusion |
|---|---|
| Sponsor | Bloodworks |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Autologous Cold-stored Apheresis Platelets (PHASE2, PHASE3)
- Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets (PHASE1, PHASE2)
- Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets (PHASE1, PHASE2)
- Cold Apheresis Platelets in PAS (PHASE1)
- Assessment of Whole Blood Cold Stored Platelets (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous Cold Stored Platelet transfusion CI brief — competitive landscape report
- Autologous Cold Stored Platelet transfusion updates RSS · CI watch RSS
- Bloodworks portfolio CI